BIO Letter to Congressional Leadership on the Give Kids a Chance Act & Reauthorization of the Pediatric Priority Review Voucher Program (PPRV)
March 7, 2025
One thing that we can all agree on is the need to give our children a fighting chance so they can lead long and productive lives. That is why it is critical to pass the bipartisan Give Kids a Chance Act and ensure the Pediatric Priority Review Voucher Program (PPRV) is reauthorized. This program will provide greater certainty to small biotech companies, but more importantly, hope to children and families living with rare diseases.
Download Full Comments Below
2025-03-07 Letter from John F. Crowley to House and Senate Leadership
Dear Congressional Leaders:On behalf of the Council of State Bioscience Associations (CSBA)—a national coalition of independent, state and territory-based organizations representing the full breadth of America’s biotechnology ecosystem—we write to…
Re: Docket No. CDC-2025-0783; Advisory Committee on Immunization Practices (ACIP) MeetingDear Dr. Zadeh and Members of the ACIP:The Biotechnology Innovation Organization (BIO) appreciates the opportunity to provide comments to the Advisory Committee…
Chairman Cassidy, Ranking Member Sanders, and distinguished Members of the Committee:Thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO), which represents more than 1,000…
One thing that we can all agree on is the need to give our children a fighting chance so they can lead long and productive lives. That is why it is critical to pass the bipartisan Give Kids a Chance Act and ensure the Pediatric Priority Review Voucher Program (PPRV) is reauthorized. This program will provide greater certainty to small biotech companies, but more importantly, hope to children and families living with rare diseases.